Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market
Lexaria, a global innovator in drug delivery platforms, just reported positive results from its applied research program conducted in collaboration…